Dosing Schedules from Published Research Phase 2 Trial Dose Groups The Phase 2 clinical trial published in NEJM employed the following dose groups, all administered via subcutaneous injection once weekly: Scroll sideways to view the full table on mobile
Pedro Mariano est completando 51 anos neste sbado (18/04)
In cosmetic products, it has been found to tighten loose skin and improve elasticity, skin density, and firmness, reduce fine lines and wrinkles, reduce photodamage and hyperpigmentation, and increase keratinocyte proliferation
Side effects and safety concerns The combination amplifies risks significantly
However, human safety data remains limited to anecdotal reports and Phase I/II trial abstracts that never reached full peer-reviewed publication
These effects are believed to result from enhanced fatty acid oxidation and improved cellular energy balance, contributing to overall metabolic health optimization